CRA International (UK) Limited is the UK-based arm of Charles River Associates (CRA), a global consulting firm founded in 1965 and headquartered in Boston. CRA International (UK) Limited was incorporated in 2000 and registered with the EU Transparency Register on 11 April 2024. The firm specializes in providing economic, financial, and strategic expertise to law firms, corporations, accounting firms, and governments worldwide. Their core competencies include management consulting, economic litigation, expert testimony, and strategic advice across a broad range of sectors.
CRA International (UK) Limited focuses its lobbying efforts primarily on healthcare and pharmaceuticals, energy and climate policy, and competition law within the EU. They support clients by conducting research, producing white papers, and informing public policy debates on key legislative files such as the revision of general pharmaceutical legislation, Europe’s Beating Cancer Plan, the European Health Data Space (EHDS), and preparedness initiatives under the Health Emergency Preparedness and Response Authority (HERA). Their work involves economic analysis to influence market and regulatory frameworks, often supporting clients in navigating complex EU regulatory environments.
The firm is part of a larger global network that includes specialized practices in antitrust and competition economics, auctions, energy, finance, intellectual property, labor and employment, life sciences, risk investigations, and transfer pricing. CRA International (UK) Limited benefits from the extensive experience and resources of its parent company, Charles River Associates, which has a history of acquisitions to expand its expertise and geographic reach, including the acquisition of Lexecon in Europe and the UK.
CRA International (UK) Limited operates as a professional consultancy and declares a relatively modest lobbying footprint within the EU, with three lobbyists registered but only 0.3 full-time equivalent dedicated to lobbying activities. The firm does not currently declare any affiliations or memberships with other organizations in the EU Transparency Register. Their declared lobbying expenditures for the financial year 2023 range between €200,000 and €299,999. While the firm is active in lobbying on significant EU dossiers, it maintains a low profile in terms of direct engagement with European Parliament accredited lobbyists.
The firm’s approach to inclusion and engagement, as reflected in its global parent company’s initiatives, emphasizes attracting top talent, fostering collaboration, and supporting diversity through scholarships, internships, and professional development programs. This cultural commitment aligns with their strategic consulting ethos and underpins their ability to deliver high-quality, data-driven insights and advice to their clients.
